Want to join the conversation?
For 1Q16, $CVS' Retail segment same-store sales rose 4.2%. The company was positively affected by approx. 125 BP due to the additional day related to the Leap Year. Pharmacy same-store sales rose 5.5%, negatively impacted by approx. 360 BP as a result of recent generic introductions and about 50 BP related to the softer flu season.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?